Immune reset: CAR-T therapy takes on autoimmune diseases
Disease control
Recruiting now
This early-stage trial tests a treatment called CAR-T cell therapy for people with severe autoimmune diseases that haven't responded to other treatments. The therapy uses a patient's own immune cells, modified to target and reset the immune system. Only 3 participants will be enr…
Phase: NA • Sponsor: ShenZhen Cell Valley • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC